{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T06:28:35Z","timestamp":1776666515786,"version":"3.51.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,8]]},"DOI":"10.7759\/cureus.40125","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T13:26:22Z","timestamp":1686230782000},"source":"Crossref","is-referenced-by-count":3,"title":["Clinical and Therapeutic Profile of Non-Hodgkin\u2019s Lymphoma: A Retrospective Study From a Najran Oncology Center"],"prefix":"10.7759","author":[{"given":"Ahmed M","family":"Badheeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fasal","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musadag","family":"Elhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasher","family":"Alyami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed  A","family":"Badheeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/11.suppl_1.S3","article-title":"Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms","volume":"11","author":"Harris NL","year":"2000","unstructured":"Harris NL, Jaffe ES, Diebold J, et al.. Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol. 2000, 11:3-10.","journal-title":"Ann Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06905.x","article-title":"The new World Health Organization-European Organization for research and treatment of cancer classification for cutaneous lymphomas: a practical marriage of two giants","volume":"153","author":"Slater DN","year":"2005","unstructured":"Slater DN. The new World Health Organization-European Organization for research and treatment of cancer classification for cutaneous lymphomas: a practical marriage of two giants. Br J Dermatol. 2005, 153:874-80. 10.1111\/j.1365-2133.2005.06905.x","journal-title":"Br J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2017.1281122","article-title":"Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic\/dendritic cell neoplasms","volume":"10","author":"Jiang M","year":"2017","unstructured":"Jiang M, Bennani NN, Feldman AL. Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic\/dendritic cell neoplasms. Expert Rev Hematol. 2017, 10:239-49. 10.1080\/17474086.2017.1281122","journal-title":"Expert Rev Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/medsci9010005","article-title":"Epidemiology of non-Hodgkin's lymphoma","volume":"9","author":"Thandra KC","year":"2021","unstructured":"Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P. Epidemiology of non-Hodgkin's lymphoma. Med Sci (Basel). 2021, 9:5. 10.3390\/medsci9010005","journal-title":"Med Sci (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-004-0939-7","article-title":"Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology","volume":"84","author":"M\u00fcller AM","year":"2005","unstructured":"M\u00fcller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005, 84:1-12. 10.1007\/s00277-004-0939-7","journal-title":"Ann Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4447-1","article-title":"The clinico-pathological profile of non-Hodgkin's lymphoma in Aseer region of Saudi Arabia","volume":"12","author":"Alyahya N","year":"2019","unstructured":"Alyahya N, Adiga B, Alwadei A, Alshahrani G, Alyahya F. The clinico-pathological profile of non-Hodgkin's lymphoma in Aseer region of Saudi Arabia. BMC Res Notes. 2019, 12:418. 10.1186\/s13104-019-4447-1","journal-title":"BMC Res Notes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/sjmms.sjmms_200_21","article-title":"Survival and epidemiologic trends of lymphomas in Saudi Arabia: a 10-year report from a tertiary care hospital","volume":"10","author":"Altowairqi MY","year":"2022","unstructured":"Altowairqi MY, Alyousef MY, Ghandour MK, et al.. Survival and epidemiologic trends of lymphomas in Saudi Arabia: a 10-year report from a tertiary care hospital. Saudi J Med Med Sci. 2022, 10:31-5. 10.4103\/sjmms.sjmms_200_21","journal-title":"Saudi J Med Med Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2015.16.5.2069","article-title":"Changing trends of adult lymphoma in the Kingdom of Saudi Arabia - comparison of data sources","volume":"16","author":"Rauf MS","year":"2015","unstructured":"Rauf MS, Akhtar S, Maghfoor I. Changing trends of adult lymphoma in the Kingdom of Saudi Arabia - comparison of data sources. Asian Pac J Cancer Prev. 2015, 16:2069-72. 10.7314\/apjcp.2015.16.5.2069","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref9","article-title":"The changing trends of adult Hodgkin's disease in Saudi Arabia","volume":"24","author":"Al-Diab AI","year":"2003","unstructured":"Al-Diab AI, Siddiqui N, Sogiawalla FF, et al.. The changing trends of adult Hodgkin's disease in Saudi Arabia. Saudi Med J. 2003, 24:617-22.","journal-title":"Saudi Med J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3934\/publichealth.2020053","article-title":"Epidemiology of cancer in Saudi Arabia thru 2010-2019: a systematic review with constrained meta-analysis","volume":"7","author":"Alqahtani WS","year":"2020","unstructured":"Alqahtani WS, Almufareh NA, Domiaty DM, et al.. Epidemiology of cancer in Saudi Arabia thru 2010-2019: a systematic review with constrained meta-analysis. AIMS Public Health. 2020, 7:679-96. 10.3934\/publichealth.2020053","journal-title":"AIMS Public Health"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2014\/8173.3988","article-title":"Immunohistochemical (IHC) analysis of non-Hodgkin\u2019s lymphoma (NHL) spectrum according to who\/real classification: a single centre experience from Punjab, India","volume":"8","author":"Sharma M","year":"2014","unstructured":"Sharma M, Mannan R, Madhukar M, Navani S, Manjari M, Bhasin TS, Gill KS. Immunohistochemical (IHC) analysis of non-Hodgkin\u2019s lymphoma (NHL) spectrum according to who\/real classification: a single centre experience from Punjab, India. J Clin Diagn Res. 2014, 8:46-9. 10.7860\/JCDR\/2014\/8173.3988","journal-title":"J Clin Diagn Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18197","article-title":"Outcomes of relapsed\/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients","volume":"198","author":"Harrysson S","year":"2022","unstructured":"Harrysson S, Eloranta S, Ekberg S, et al.. Outcomes of relapsed\/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients. Br J Haematol. 2022, 198:267-77. 10.1111\/bjh.18197","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.6.368","article-title":"Staging non-Hodgkin lymphoma","volume":"55","author":"Armitage JO","year":"2005","unstructured":"Armitage JO. Staging non-Hodgkin lymphoma. CA Cancer J Clin. 2005, 55:368-76. 10.3322\/canjclin.55.6.368","journal-title":"CA Cancer J Clin"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-11840-3","article-title":"Non Hodgkin lymphoma in Lebanon: a retrospective epidemiological study between 1984 and 2019","volume":"21","author":"Touma E","year":"2021","unstructured":"Touma E, Antoun L, Hallit S, Nasr F, Massoud M, El Othman R, Chahine G. Non Hodgkin lymphoma in Lebanon: a retrospective epidemiological study between 1984 and 2019. BMC Public Health. 2021, 21:1820. 10.1186\/s12889-021-11840-3","journal-title":"BMC Public Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2009.07.009","article-title":"Lymphoma in adolescents and young adults","volume":"36","author":"Jaglowski SM","year":"2009","unstructured":"Jaglowski SM, Linden E, Termuhlen AM, Flynn JM. Lymphoma in adolescents and young adults. Semin Oncol. 2009, 36:381-418. 10.1053\/j.seminoncol.2009.07.009","journal-title":"Semin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics","volume":"67","author":"Siegel RL","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2017, 67:7-30. 10.3322\/caac.21387","journal-title":"CA Cancer J Clin"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-03918-6","article-title":"RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group","volume":"99","author":"Bastos-Oreiro M","year":"2020","unstructured":"Bastos-Oreiro M, Munta\u00f1ola A, Panizo C, et al.. RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group. Ann Hematol. 2020, 99:799-808. 10.1007\/s00277-020-03918-6","journal-title":"Ann Hematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.21037\/apm-19-589","article-title":"Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center","volume":"9","author":"Huang H","year":"2020","unstructured":"Huang H, Fan L, Fu D, Lin Q, Shen J. Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center. Ann Palliat Med. 2020, 9:1442-52. 10.21037\/apm-19-589","journal-title":"Ann Palliat Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002729","article-title":"International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI","volume":"135","author":"Ruppert AS","year":"2020","unstructured":"Ruppert AS, Dixon JG, Salles G, et al.. International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI. Blood. 2020, 135:2041-8. 10.1182\/blood.2019002729","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061747","article-title":"Long-term follow-up of bridging therapies prior to CAR T-cell therapy for relapsed\/refractory large B cell lymphoma","volume":"15","author":"Ladbury C","year":"2023","unstructured":"Ladbury C, Dandapani S, Hao C, et al.. Long-term follow-up of bridging therapies prior to CAR T-cell therapy for relapsed\/refractory large B cell lymphoma. Cancers (Basel). 2023, 15:1747. 10.3390\/cancers15061747","journal-title":"Cancers (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","year":"1993","unstructured":"A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993, 329.987-94. 10.1056\/NEJM199309303291402","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.6.2065","article-title":"Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis","volume":"16","author":"G\u00f3mez H","year":"1998","unstructured":"G\u00f3mez H, Hidalgo M, Casanova L, et al.. Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis. J Clin Oncol. 1998, 16:2065-9. 10.1200\/JCO.1998.16.6.2065","journal-title":"J Clin Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma","volume":"339","author":"Miller TP","year":"1998","unstructured":"Miller TP, Dahlberg S, Cassady JR, et al.. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med. 1998, 339:21-6. 10.1056\/NEJM199807023390104","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31820c011a","article-title":"Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment","volume":"56","author":"Bateganya MH","year":"2011","unstructured":"Bateganya MH, Stanaway J, Brentlinger PE, Magaret AS, Wald A, Orem J, Casper C. Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment. J Acquir Immune Defic Syndr. 2011, 56:312-9. 10.1097\/QAI.0b013e31820c011a","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.03.013","article-title":"Emergency admission and survival from aggressive non-Hodgkin lymphoma: a report from the UK\u2019s population-based haematological malignancy Research Network","volume":"78","author":"Kane E","year":"2017","unstructured":"Kane E, Howell D, Smith A, Crouch S, Burton C, Roman E, Patmore R. Emergency admission and survival from aggressive non-Hodgkin lymphoma: a report from the UK\u2019s population-based haematological malignancy Research Network. Eur J Cancer. 2017, 78:53-60. 10.1016\/j.ejca.2017.03.013","journal-title":"Eur J Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5581\/1516-8484.20130055","article-title":"The utility of lactate dehydrogenase in the follow up of patients with diffuse large B-cell lymphoma","volume":"35","author":"William BM","year":"2013","unstructured":"William BM, Bongu NR, Bast M, Bociek RG, Bierman PJ, Vose JM, Armitage JO. The utility of lactate dehydrogenase in the follow up of patients with diffuse large B-cell lymphoma. Rev Bras Hematol Hemoter. 2013, 35:189-91. 10.5581\/1516-8484.20130055","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S399336","article-title":"Construction and validation of a novel nomogram for predicting the recurrence of diffuse large B cell lymphoma treated with R-CHOP","volume":"16","author":"Gong Y","year":"2023","unstructured":"Gong Y, Yan H, Yang Y, Zhai B, Huang Z, Zhang Z. Construction and validation of a novel nomogram for predicting the recurrence of diffuse large B cell lymphoma treated with R-CHOP. Pharmgenomics Pers Med. 2023, 16:291-301. 10.2147\/PGPM.S399336","journal-title":"Pharmgenomics Pers Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0578-1310.2017.10.007","article-title":"Clinical pathologic characteristics and treatment outcomes of 19 relapsed pediatric B-cell lymphoma (Article in Chinese)","volume":"55","author":"Huang S","year":"2017","unstructured":"Huang S, Jin L, Yang J, et al.. Clinical pathologic characteristics and treatment outcomes of 19 relapsed pediatric B-cell lymphoma (Article in Chinese). Zhonghua Er Ke Za Zhi. 2017, 55:748-53. 10.3760\/cma.j.issn.0578-1310.2017.10.007","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-C\u00e9ligny P","year":"2004","unstructured":"Solal-C\u00e9ligny P, Roy P, Colombat P, et al.. Follicular lymphoma international prognostic index. Blood. 2004, 104:1258-65. 10.1182\/blood-2003-12-4434","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_2432_21","article-title":"Diffuse large B-cell lymphoma and new insights into its pathobiology and implication in treatment","volume":"11","author":"Mamgain G","year":"2022","unstructured":"Mamgain G, Singh PK, Patra P, Naithani M, Nath UK. Diffuse large B-cell lymphoma and new insights into its pathobiology and implication in treatment. J Family Med Prim Care. 2022, 11:4151-8. 10.4103\/jfmpc.jfmpc_2432_21","journal-title":"J Family Med Prim Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/159048-clinical-and-therapeutic-profile-of-non-hodgkins-lymphoma-a-retrospective-study-from-a-najran-oncology-center","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:14Z","timestamp":1707508874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/159048-clinical-and-therapeutic-profile-of-non-hodgkins-lymphoma-a-retrospective-study-from-a-najran-oncology-center"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.40125","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,8]]}}}